Journal of Pharmacology and Experimental Therapeutics: 276 (1)

January 01, 1996; Volume 276,Issue 1

Article

You have access
ERRATUM
Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 352;

You have access
A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
S H Graham, J Chen, J Q Lan and R P Simon

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 1-4;
You have access
Novel anti-inflammatory compounds prevent CD11b/CD18, alpha M beta 2 (Mac-1)-dependent neutrophil adhesion without blocking activation-induced changes in Mac-1.
G Endemann, Y Feng, C M Bryant, G S Hamilton, J Perumattam, R E Mewshaw and D Y Liu

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 5-12;
You have access
Tachyphylaxis to angiotensin II and [Phe4]-angiotensin II in the rat mesentery in vivo.
S P Tofovic and E K Jackson

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 13-20;
You have access
Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding.
J Thornton-Manning, M L Appleton, F J Gonzalez and G S Yost

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 21-29;
You have access
Determination of Km for oxygen of nitric oxide synthase isoforms.
A Rengasamy and R A Johns

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 30-33;
You have access
The effects of clomipramine on the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro.
R D Trifunović and M S Brodie

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 34-40;
You have access
Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
G D Bartoszyk, J Harting and K O Minck

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 41-48;
You have access
Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
N Hotta, N Koh, F Sakakibara, J Nakamura, Y Hamada, T Wakao, T Hara, K Mori, K Naruse, E Nakashima and N Sakamoto

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 49-55;
You have access
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
F Rodríguez de Fonseca, P Rubio, F Menzaghi, E Merlo-Pich, J Rivier, G F Koob and M Navarro

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 56-64;
You have access
Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray.
P J Monroe, A A Hawranko, D L Smith and D J Smith

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 65-73;
You have access
The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions.
M H Chin, C L Cioffi, M Garay, R F Neale, S S Shetty, D DelGrande, B Mugrage, M A Sills and K E Lipson

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 74-83;
You have access
YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
M Shimizu-Sasamata, S Kawasaki-Yatsugi, M Okada, S Sakamoto, S Yatsugi, J Togami, K Hatanaka, J Ohmori, K Koshiya, S Usuda and K Murase

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 84-92;
You have access
A novel P1 purinoceptor activates an outward K+ current in follicular oocytes of Xenopus laevis.
B F King, J Pintor, S Wang, A U Ziganshin, L E Ziganshina and G Burnstock

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 93-100;
You have access
Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene.
W Tassaneeyakul, D J Birkett, J W Edwards, M E Veronese, W Tassaneeyakul, R H Tukey and J O Miners

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 101-108;
You have access
Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
J X Mazoit, L S Cao and K Samii

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 109-115;
You have access
The role of 5-HT3 receptors in periaqueductal gray-induced inhibition of nociceptive dorsal horn neurons in rats.
Y B Peng, Q Lin and W D Willis

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 116-124;
You have access
Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.
R M Edwards, W Trizna, E J Stack and J Weinstock

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 125-129;
You have access
Beta adrenergic receptor activation attenuates the generation of inositol phosphates in the pregnant rat myometrium. Correlation with inhibition of Ca++ influx, a cAMP-independent mechanism.
L D Khac, S Arnaudeau, N Lepretre, J Mironneau and S Harbon

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 130-136;
You have access
Tetrahydro-9-aminoacridine has mixed actions on muscarinic currents and blocks opioid currents in rat locus ceruleus neurons.
P B Osborne and M J Christie

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 137-142;
You have access
Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells.
C J Hough, R P Irwin, X M Gao, M A Rogawski and D M Chuang

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 143-149;
You have access
ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.
K Shiosaki, P Jenner, K E Asin, D R Britton, C W Lin, M Michaelides, L Smith, B Bianchi, S Didomenico, L Hodges, Y Hong, L Mahan, J Mikusa, T Miller, A Nikkel, M Stashko, D Witte and M Williams

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 150-160;
You have access
Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
S Subramaniam, S D Donevan and M A Rogawski

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 161-168;
You have access
Evidence that a nereistoxin metabolite, and not nereistoxin itself, reduces neuronal nicotinic receptors: studies in the whole chick ciliary ganglion, on isolated neurons and immunoprecipitated receptors.
Y Xie, T McHugh, J McKay, G S Jones and R H Loring

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 169-177;
You have access
Acetylcholine-induced chloride current oscillations in swine tracheal smooth muscle cells.
X Liu and J M Farley

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 178-186;
You have access
Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
M Hatch, R W Freel, S Shahinfar and N D Vaziri

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 187-193;
You have access
ATP depletion by iodoacetate and cyanide in renal distal tubular cells.
L H Lash, J J Tokarz, Z Chen, B M Pedrosi and E B Woods

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 194-205;
You have access
Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
D Wu, R J Boado and W M Pardridge

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 206-211;
You have access
Electrocorticographic desynchronization after application of visceral and somatic noxious stimuli in urethane-anesthetized rats: effect of intrathecal administration of tachykinin (NK 1 or NK 2) receptor antagonists.
B Conte, C Cutrufo and S Manzini

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 212-218;
You have access
Uptake of cimetidine into syncytial microvillus membrane vesicles of human term placenta.
E M van der Aa, A C Wouterse, C E Verrijt, J H Peereboom-Stegeman and F G Russel

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 219-222;
You have access
Autoradiographic evidence for the modulation of in vivo sigma receptor labeling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain.
P Bouchard, F Roman, J L Junien and R Quirion

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 223-230;
You have access
A catechol derivative (4-methylcatechol) accelerates the recovery from experimental acrylamide-induced neuropathy.
K Saita, T Ohi, Y Hanaoka, S Furukawa, Y Furukawa, K Hayashi and S Matsukura

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 231-237;
You have access
Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP.
J S Sidhu and C J Omiecinski

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 238-245;
You have access
Cationized hyperimmune immunoglobulins: pharmacokinetics, toxicity evaluation and treatment of human immunodeficiency virus-infected human-peripheral blood lymphocytes-severe combined immune deficiency mice.
W M Pardridge, Y S Kang, A Diagne and J A Zack

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 246-252;
You have access
Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms.
L Y Chen and J L Mehta

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 253-257;
You have access
Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity.
J C Kraner, E T Morgan, T S Poet, S L Born, V L Burnett and J R Halpert

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 258-264;
You have access
The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.
G Yue, F F Sun, C Dunn, K Yin and P Y Wong

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 265-270;
You have access
Long-term safety of the aminobisphosphonate alendronate in adult dogs. I. General safety and biomechanical properties of bone.
C P Peter, J Guy, M Shea, W Bagdon, W F Kline and W C Hayes

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 271-276;
You have access
Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.
R Balena, A Markatos, J G Seedor, M Gentile, C Stark, C P Peter and G A Rodan

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 277-283;
You have access
125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
T Hussain, J Linden and S J Mustafa

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 284-288;
You have access
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
M Gopalakrishnan, L M Monteggia, D J Anderson, E J Molinari, M Piattoni-Kaplan, D Donnelly-Roberts, S P Arneric and J P Sullivan

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 289-297;
You have access
Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
J B McMahon, R W Buckheit, R J Gulakowski, M J Currens, D T Vistica, R H Shoemaker, S F Stinson, J D Russell, J P Bader, V L Narayanan, R J Schultz, W G Brouwer, E E Felauer and M R Boyd

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 298-305;
You have access
Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.
K L Widnell, D W Self, S B Lane, D S Russell, V A Vaidya, M J Miserendino, C S Rubin, R S Duman and E J Nestler

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 306-315;
You have access
The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
X Tao, L S Davis, K Hashimoto and P E Lipsky

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 316-325;
You have access
Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
D J Hnatowich, G Mardirossian, M Fogarasi, T Sano, C L Smith, C R Cantor, M Rusckowski and P Winnard

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 326-334;
You have access
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes.
G Rossoni, A Sala, F Berti, T Testa, C Buccellati, C Molta, R Muller-Peddinghaus, J Maclouf and G C Folco

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 335-341;
You have access
Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation.
D G Standaert, C M Testa, G D Rudolf and Z R Hollingsworth

Journal of Pharmacology and Experimental Therapeutics January 1996, 276 (1) 342-352;

Main menu

User menu

Search

Table of Contents

Article

In this issue

Jump to

Navigate

More Information

ASPET's Other Journals